Quarterly report pursuant to Section 13 or 15(d)

Statements Of Condensed Consolidated Cash Flows

v2.4.0.8
Statements Of Condensed Consolidated Cash Flows (USD $)
In Millions, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
OPERATING ACTIVITIES    
Net income $ 376.0 $ 744.2
Adjustments to reconcile net income to net cash provided (used) by operating activities:    
Depreciation, depletion and amortization 438.0 382.3
Derivatives and currency hedges 0.4 12.0
Equity loss in ventures (net of tax) 73.9 22.7
Deferred income taxes (39.5) (352.5)
Changes in deferred revenue and below-market sales contracts (52.2) (36.2)
Other (18.3) (55.7)
Changes in operating assets and liabilities:    
Receivables and other assets 36.2 (118.6)
Product inventories (10.8) (70.4)
Payables and accrued expenses (117.8) (252.3)
Net cash provided by operating activities 685.9 275.5
INVESTING ACTIVITIES    
Purchase of property, plant and equipment (742.2) (793.6)
Other investing activities 7.8 8.9
Net cash used by investing activities (734.4) (784.7)
FINANCING ACTIVITIES    
Net proceeds from issuance of Series A, Mandatory Convertible Preferred Stock, Class A 709.4 0
Net proceeds from issuance of common shares 285.3 0
Repayment of term loan (847.1) (49.9)
Borrowings under credit facilities 567.0 670.0
Repayment under credit facilities (512.0) (420.0)
Proceeds from equipment loan 62.1 0
Contributions by joint ventures, net 17.7 68.8
Common stock dividends (68.8) (217.8)
Preferred stock dividends (23.0) 0
Other financing activities (28.6) (23.9)
Net cash provided by financing activities 162.0 27.2
EFFECT OF EXCHANGE RATE CHANGES ON CASH (9.9) (0.1)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 103.6 (482.1)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 195.2 521.6
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 298.8 $ 39.5